BioXcel Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
bioxcel-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
| # | Institution | Value |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC(2024-12-31) | $1.6M |
| 2 | UBS Group AG(2024-12-31) | $477.6K |
| 3 | VANGUARD GROUP INC(2024-12-31) | $444.1K |
| 4 | BlackRock, Inc.(2024-12-31) | $142.3K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC(2024-12-31) | $116.7K |
| 6 | WELLS FARGO & COMPANY/MN(2024-12-31) | $74.4K |
| 7 | MILLENNIUM MANAGEMENT LLC(2024-12-31) | $39.2K |
| 8 | RENAISSANCE TECHNOLOGIES LLC(2024-12-31) | $29.1K |
| 9 | STATE STREET CORP(2024-12-31) | $28.8K |
| 10 | NORTHERN TRUST CORP(2024-12-31) | $27.6K |
| 11 | Squarepoint Ops LLC(2024-12-31) | $26.9K |
| 12 | CITADEL ADVISORS LLC(2024-12-31) | $22.2K |
| 13 | BANK OF AMERICA CORP /DE/(2024-12-31) | $19.8K |
| 14 | DIVERSIFY WEALTH MANAGEMENT, LLC(2024-12-31) | $15.1K |
| 15 | Arete Wealth Advisors, LLC(2024-12-31) | $15.0K |
| 16 | Hennion & Walsh Asset Management, Inc.(2024-12-31) | $14.7K |
| 17 | Cambridge Investment Research Advisors, Inc.(2024-12-31) | $14.0K |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP(2024-12-31) | $12.9K |
| 19 | MORGAN STANLEY(2024-12-31) | $9.6K |
| 20 | HRT FINANCIAL LP(2024-12-31) | $9.0K |
As of 2024-12-31
Value:$1.6M
As of 2024-12-31
Value:$477.6K
As of 2024-12-31
Value:$444.1K
As of 2024-12-31
Value:$142.3K
As of 2024-12-31
Value:$116.7K
As of 2024-12-31
Value:$74.4K
As of 2024-12-31
Value:$39.2K
As of 2024-12-31
Value:$29.1K
As of 2024-12-31
Value:$28.8K
As of 2024-12-31
Value:$27.6K
As of 2024-12-31
Value:$26.9K
As of 2024-12-31
Value:$22.2K
As of 2024-12-31
Value:$19.8K
As of 2024-12-31
Value:$15.1K
As of 2024-12-31
Value:$15.0K
As of 2024-12-31
Value:$14.7K
As of 2024-12-31
Value:$14.0K
As of 2024-12-31
Value:$12.9K
As of 2024-12-31
Value:$9.6K
As of 2024-12-31
Value:$9.0K
Total Institutional Holders:50
Top 10 Holders Own:92.8%